<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[byetta Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/byetta.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to byetta]]></description>
	<s:counts start="0" returned="4" found="4" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Amylin Insists Byetta Doesn't Cause Cancer; Wall Street Doesn't Seem So Sure]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001760/amylin-insists-byetta-doesnt-cause-cancer-wall-street-doesnt-seem-so-sure/]]></link>
		<description><![CDATA[Amylin CEO Daniel Bradbury may be wishing that Novo Nordisk's failed competitor to its diabetes drug Byetta had actually been approved by the FDA. Had Novo's liraglutide passed muster, no one would have gotten the jitters over whether Byetta gives you cancer or not.    At Amylin's conference...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 21 Apr 2009 13:27:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/byetta.html"><![CDATA[Byetta]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Icahn Bruising For Proxy Battle With Amylin Management]]></title>
		<link><![CDATA[http://blogs.bnet.com/secdocuments/?p=249]]></link>
		<description><![CDATA[    [caption id="attachment_248" align="alignleft" width="200" caption="Byetta"][/caption]      Activist investor Carl Icahn announced in a regulatory filing with the Securities and Exchange Commission his intention to nominate a slate of five directors to the board of Amylin Pharmaceuticals at the drugmakerâ€™s May 2009 annual...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 29 Jan 2009 22:44:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/byetta.html"><![CDATA[Byetta]]></category>
		<category domain="http://resources.bnet.com/topic/activist+investor+carl+icahn.html"><![CDATA[Activist Investor Carl Icahn]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/david+phillips.html"><![CDATA[David Phillips]]></category>
		<category domain="http://resources.bnet.com/topic/david+phillips.html"><![CDATA[David Phillips]]></category>
	</item>
	<item>
		<title><![CDATA[Behind the Byetta Crisis: Is This Drug Really All That and a Bag of (Fat-Free) Chips?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000189/behind-the-byetta-crisis-is-this-drug-really-all-that-and-a-bag-of-fat-free-chips/]]></link>
		<description><![CDATA[The current big headache for Eli Lilly and Amylin is their diabetes drug Byetta, which the FDA has linked to six cases of fatal pancreatitis.    The two companies, which jointly market the drug, held a conference call yesterday in which they hoped to calm nervous investors. (It...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 28 Aug 2008 07:32:53 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/chip.html"><![CDATA[Chip]]></category>
		<category domain="http://resources.bnet.com/topic/byetta.html"><![CDATA[Byetta]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/nausea.html"><![CDATA[Nausea]]></category>
		<category domain="http://resources.bnet.com/topic/americans+with+disabilities+act+%2528ada%2529.html"><![CDATA[Americans With Disabilities Act (ADA)]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+governance.html"><![CDATA[Corporate Governance]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Stocks on the Rise.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200506/ai_n19991120]]></link>
		<description><![CDATA[M2 PRESSWIRE-17 June 2005-WallStreetGrapevine: Stocks on the  RiseC1994-2005 M2 COMMUNICATIONS LTD    RDATE:17062005    Wall Street, NYC - Today, wallstreetgrapevine.com, named; FacePrint  Global Solutions Inc. (OTC BB: FCPG), Vicuron Pharmaceuticals Inc.  (Nasdaq NM: MICU), Immunicon Corporation (Nasdaq NM: IMMC), and Amylin  Pharmaceuticals...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 17 Jun 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/byetta.html"><![CDATA[BYETTA]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/immunicon+corp..html"><![CDATA[Immunicon Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/infection.html"><![CDATA[infection]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMMC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">IMMC,NDAQ,PFE</category>
	</item>
</channel>
</rss>
